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Background: Multiple cell types including trophoblasts, osteoclasts and myoblasts require somatic cell fusion events
as part of their physiological functions. In Drosophila Melanogaster the paralogus type 1 transmembrane receptors
and members of the immunoglobulin superfamily Kin of Irre (Kirre) and roughest (Rst) regulate myoblast fusion during
embryonic development. Present within the human genome are three homologs to Kirre termed Kin of Irre like (Kirrel)
1, 2 and 3. Currently it is unknown if Kirrel3 is expressed in adult human skeletal muscle.
Results: We investigated (using PCR and Western blot) Kirrel3 in adult human skeletal muscle samples taken at
rest and after mild exercise induced muscle damage. Kirrel3 mRNA expression was verified by sequencing and
protein presence via blotting with 2 different anti-Kirrel3 protein antibodies. Evidence for three alternatively
spliced Kirrel3 mRNA transcripts in adult human skeletal muscle was obtained. Kirrel3 mRNA in adult human
skeletal muscle was detected at low or moderate levels, or not at all. This sporadic expression suggests that
Kirrel3 is expressed in a pulsatile manner. Several anti Kirrel3 immunoreactive proteins were detected in all
adult human skeletal muscle samples analysed and results suggest the presence of different isoforms or
posttranslational modification, or both.
Conclusion: The results presented here demonstrate for the first time that there are at least 3 splice variants
of Kirrel3 expressed in adult human skeletal muscle, two of which have never previously been identified in
human muscle. Importantly, mRNA of all splice variants was not always present, a finding with potential
physiological relevance. These initial discoveries highlight the need for more molecular and functional studies
to understand the role of Kirrel3 in human skeletal muscle.
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Somatic cell fusion events are critical for development of
multicellular eukaryotic organisms. Postnatal growth and
repair also frequently rely on somatic cell fusion events,
especially in tissues such as skeletal muscle that con-
tain multinucleated cells. However, the genes and molecu-
lar mechanisms underpinning this fundamental cellular
process in humans are largely unknown. Multiple cell
types including trophoblasts, osteoclasts and skeletal
muscle require somatic cell fusion events in order to per-
form their physiological functions [1-3]. The occurrence
of cell fusion events in skeletal muscle provides a potential
mechanism for the introduction of exogenous DNA to* Correspondence: khm@sun.ac.za
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unless otherwise stated.cure genetic myopathies, while increasing evidence is
emerging that fusion of cancer cells and bone marrow
derived cells may enable and promote cancer metastasis
[4-7]. Therefore, an improved understanding of how
somatic cells fuse will likely have diverse clinical benefits.
In humans, a single skeletal muscle fibre can contain
thousands of nuclei [8]. Each nucleus present in the
muscle fibre arises from asynchronous cell fusion events.
Post birth, skeletal muscle is a very adaptable tissue that
is capable of repairing itself in response to injury such as
that which accrues from damage-inducing exercise bouts
[9,10]. The regeneration capacity of skeletal muscle is
largely due to the presence of stem cell-like progenitor
cells, termed satellite cells, that reside between the basal
lamina and plasma membrane [11]. Satellite cells are typ-
ically found in an inactive state, however, in response
to muscle injury they proliferate and also fuse (eitherLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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muscle repair [12-14]. The large amount of fusion events
that occur during development, growth and repair of skel-
etal muscle make it a suitable tissue for studies aiming
to identify the genes and mechanisms that underpin the
somatic cell fusion process.
Research findings from Drosophila have highlighted
that key events in the muscle cell fusion process are cell-
cell attraction, adhesion and subsequent actin nucleation
at sites of cell-cell adhesion, the latter enabling membrane
fusion [15-17]. A wide variety of genes impact on the
muscle cell fusion process ranging from actin nucleation
factors, such as those found in the actin related protein 2/3
complex [18], to type 1 transmembrane receptors [19,20].
Of particular interest to this research paper has been the
discovery of two paralogus type 1 transmembrane recep-
tors and members of the immunoglobulin (Ig) superfamily
Kirre [21] and Rst [22]. Loss of both Kirre and Rst from
the Drosophila genome results in muscle cell fusion inhib-
ition [19].
Present within the human genome are three Kirre homo-
logs termed Kin of Irre like (Kirrel) 1 ,2 and 3 [23]. This
family of genes have also been referred to in the literature
as the Neph family, Neph1 (Kirrel1), Neph2 (Kirrel3), and
Neph3 (Kirrel2)[23,24]. Kirrel3 has been implicated in
diverse functions including pontine nuclei formation in the
developing brain [25] male-male aggressive behaviour [26]
and inhibition of hematopoietic stem cell differentiation
[27]. Notably, no detailed investigation has been performed
on any of the Kirrel family members and their presence in
human skeletal muscle. Of particular interest to this re-
search paper is the Kirrel3 gene as murine kirrel3 has been
reported to be present in the kidney [28], brain [25] and
also in cultured stromal cells [27], yet, results from mRNA
analysis of murine skeletal muscle suggest that Kirrel3 is
absent [27]. However, a different study reported Kirrel3
immunoreactivity in lysates obtained from mouse skeletal
muscle [28]. These conflicting reports on Kirrel3 in mam-
malian skeletal muscle merit further investigation.
Our primary aim was to assess whether Kirrel3 is present
in uninjured and regenerating human skeletal muscle fol-
lowing mild damage-inducing exercises such as plyomet-
ric jumping and downhill running. Presence of Kirrel3 in
the afore mentioned samples would raise questions about
its function in skeletal muscle. Currently nothing is known
about Kirrel3 in this tissue, or if it is indeed present in
adult human skeletal muscle. While its presence alone
would not confirm a role in the human muscle cell fusion
process, it would provide initial support for further inves-
tigation. It is possible that it could mirror the role of Kirre,
its Drosophila homolog, in regulating myoblast fusion
events in adult human muscle.
Our research findings demonstrate that at least three
alternative splice variants of Kirrel3 are present in adulthuman skeletal muscle. Two of these splice variants have
not been previously reported in the published literature.
Detection of Kirrel3 mRNA in adult human skeletal
muscle using standard PCR was sporadic with occasional
detection in uninjured and regenerating skeletal muscle
samples. Semi nested PCR increased the detection rate.
Such sporadic detection, using standard PCR assessment,
demonstrates that in adult human skeletal muscle Kirrel3
mRNA is present at very low levels. At the protein level,
Kirrel3 immunoreactive proteins in uninjured and regen-
erating adult human skeletal muscle were observed.
Further work is now required in order to ascertain the
function of all Kirrel3 splice variants in human skeletal
muscle and to provide more insight into stimuli promot-
ing its expression and its subsequent post-transcriptional
regulation.
Results
Analysis of the National Centre for Biotechnology (NCBI)
gene database highlighted the presence of two human
Kirrel3 reference sequences NM_032531.3 (hereafter re-
ferred to as Kirrel3 A) containing 3777 nucleotides and
NM_001161707.1 (hereafter referred to as Kirrel3 B) con-
taining 2534 nucleotides. Aligning Kirrel3 A and B mRNA
transcripts to the human genome via DNA sequence
present in the genomic contig NT_033899.8, demon-
strated that Kirrel3 A has 17 exons while B has 14 exons
(see Figure 1A for schematic). Of particular note in both
transcripts was the very large first intron which spanned
approximately 438 kilo bases (KB). Both transcripts are
predicted to start their translation initiation in their first
exons. The first 2057 nucleotides of Kirrel3 A and B are
identical. This region spans exons 1-14 of Kirrel3 A. Sub-
sequently Kirrel3 A has a splice site that is not present in
B thus resulting in exon 14 of Kirrel3 B containing an add-
itional 477 nucleotides. The predicted stop codon (TAA)
in Kirrel3 B is 107 nucleotides 3′ to the missed splice site.
In comparison to Kirrel3 B, Kirrel3 A has an additional 3
exons totalling 1720 nucleotides 3′ to the missed spliced
site. The stop codon (TAA) for Kirrel3 A is located in
exon its 17th exon 641 nucleotides 3′ to the missed spliced
site in B. The 3′ untranslated regions of Kirrel3 A and B
are 1079 and 370 nucleotides respectively.
In silico analysis of Kirrel3 protein domains
Kirrel3 A is the larger of the two Kirrel3 proteins with 778
amino acids (AA) while Kirrel3 B has 600 AA. The first
565 AA of Kirrel3 A and B are identical. Domains pre-
dicted within this region (see Figure 1B for schematic) are
a signal peptide (AA1-21 http://www.cbs.dtu.dk/services/
SignalP/), five extracellular Ig domains (AA 49-146, 152-
239, 251-332, 336-417, 420-516 http://scansite.mit.edu/)
and a transmembrane domain (AA 536-558 http://www.
cbs.dtu.dk/services/TMHMM/). Five putative N-linked
Figure 1 Schematic of the exon structure of Kirrel3 A and B mRNA transcripts. A – Schematic of the exon structure of Kirrel3 A and B
mRNA transcripts. Start codon is highlighted as ATG and stop codon as TAA. The unusually large first intron is highlighted. The exons to which
primers are targeted are also shown. PS1F – Primer set 1 forward primer, PS2F – Primer set 2 forward primer, PS1R – Primer set 1 reverse primer,
PS3R – Primer set 3 reverse primer. B – Schematic of the predicted protein domains and putative N-linked glycosylation sites of Kirrel3 A and B.
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www.cbs.dtu.dk/services/NetNGlyc/) are predicted to be
present in the extracellular domain of both Kirrel3 pro-
teins. The intracellular domain of Kirrel3 A is predicted to
contain an amphysisin SH3 binding domain (AA 759-773
http://scansite.mit.edu/). Also present at its C-terminal
end is a Post Synaptic density protein 95, Drosophila discs
Large tumour suppressor, zonula occludens (PDZ) binding
domain corresponding to the amino acids THV [29].
Kirrel3 B is not predicted to contain either of the afore
mentioned intracellular domains.
Analysis of mRNA
To assess for the presence of Kirrel3 A and B mRNA in
adult human skeletal muscle, gene specific primers were
designed. We initially investigated Kirrel3 mRNA ex-
pression in adult human male skeletal muscle biopsies
obtained pre and 4 and 24 hr post a plyometric jumping
exercise in order to assess for Kirrel3 in uninjured and
mildly injured skeletal muscle. The plyometric jumping
protocol used here has previously been demonstrated to
induce mild muscle damage [30]. Kirrel3 has previously
been reported to be present in the mouse brain [31] and
for the current study human astrocytes were used as a
positive control for Kirrel3 mRNA expression.
Primer set 1 was specific to Kirrel3 A with a forward
primer targeting exon 12 and a reverse primer targetingexon 16 of Kirrel3 A (see Figure 1A for schematic on pri-
mer position). The expected amplicon is 391 nucleotides.
Two distinct amplicons migrating at approximately 370
and 400 nucleotides were detected in the biopsy taken from
subject 1 at 24 hr post plyometric exercise (Figure 2A). In
contrast, only the approximately 370 nucleotide amplicon
was detectable in the biopsy sample that was taken at the
4 hr post plyometric exercise time point from the same
subject (Figure 2A). No biopsy from Subject 2 presented
with either the approximately 370 or 400 nucleotide
amplicon. Subject 3 had the approximately 370 nucleotide
amplicon present at the baseline time point, but not at
4 hr or 24 hr post plyometric exercise (Figure 2A). The
quality of cDNA template in all human skeletal muscle
samples (except for subject 1 baseline) was confirmed as
satisfactory via assessing for GAPDH mRNA expression
(Figure 2A). A semi nested PCR was performed with pri-
mer sets 1 and 2 to assess if this approach would yield
more consistent Kirrel3 mRNA detection. Primer set 2
contained a forward primer that was targeted towards
exon 12 of Kirrel3 A with the reverse primer being the
same as in primer set 1 (see Figure 1A for schematic of
primer location). Three samples from subject 2 were nega-
tive for all amplicons in the first analysis. However, in one
of these an amplicon of approximately 370 nucleotides
was detected at the 4 hr time point using the semi-nested
PCR (Figure 2B). In human astrocytes two amplicons were
Figure 2 Detection of Kirrel3 splice variants with primer set 1. A – PCR amplicons obtained with Kirrel3 primer set 1 to detect Kirrel3 A.
mRNA was isolated from adult human skeletal muscle at rest and 4 hr and 24 hr post performance of a plyometric jumping (PLYO) exercise
(S = subject) and culture human astrocytes. *Note - the unlabelled lane came from subject 1 baseline, however, its GAPDH level was very low
and hence, it has not been commented on in this manuscript. B – Results obtained using a nested PCR approach with Kirrel3 primer set 1 and 2
on biopsy samples from subject 2 from Figure A. C – Additional PCR amplicon (500 nucleotides) was detected using Kirrel3 Primer set 1 from a
subset of adult human skeletal muscle biopsies that were obtained from participants one and two days post a downhill run (DHR) exercise bout.
D – Schematic of the exon structure of amplicons detected in A and B after excision of the bands from the gels and nucleotide sequencing.
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nucleotides (Figure 2A) thus matching those observed in
human skeletal muscle. A much fainter amplicon was also
detected in astrocytes at approximately 500 nucleotides
(Figure 2A). We also analysed mRNA extracted from
biopsies obtained from a previous study by our research
group that investigated the effects of downhill running on
skeletal muscle [32]. In some of these samples, an ampli-
con was detected that matched of the approximate 500
nucleotide amplicon observed in astrocytes (Figure 2C).
All three differently sized amplicons detected in adult
human skeletal muscle samples were excised from the
gel and sequenced. Aligning the sequence data obtained
from the approximately 370, 400 and 500 nucleotide
sized amplicons to the human genome via the Basic
Local Alignment Search Tool (BLAST available at http://
blast.ncbi.nlm.nih.gov/Blast.cgi) demonstrated that they
were all variants of Kirrel3 (see Figure 2D for schematic of
exon structure and Table 1 for raw sequence data). The
approximately 400 nucleotide amplicon corresponded to a
known sequence present in Kirrel3 A. The 37 nucleotide
containing exon 13 of Kirrel3 A was spliced out of the
approximately 370 nucleotide amplicon. Analysis of theapproximate 500 nucleotide amplicon sequence highlighted
the presence of an additional exon of 93 nucleotides
between exon 15 and 16 of Kirrel3A. This novel exon is
located approximately 3100 nucleotides 3′ to exon 15 of
Kirrel3 A and 355 nucleotides 5′ to exon 16 of Kirrel3 A.
Subsequently it was of interest to ascertain whether
Kirrel3 B mRNA was present in adult human skeletal
muscle and astrocytes. The same samples as those from the
plyometric jumping exercise intervention were assessed for
Kirrel3 B mRNA using primer set 3 that contained the
same forward primer as primer set 2 and a reverse primer
targeted towards a Kirrel3 B specific sequence present in
its 14th exon. The predicted amplicon was 607 nucleo-
tides. No amplicon was detectable in adult human skel-
etal muscle samples from either the plyometric jumping
protocol (Figure 3B) or the downhill running samples
(Data not shown), however, two amplicons migrating at
approximately 610 and 590 nucleotides were detected in
astrocytes (Figure 3B). Both amplicons were excised from
the gel and sequenced. The amplicon migrating at
approximately 610 nucleotide corresponded to Kirrel3 B
while the amplicon that migrated at approximately 590
nucleotides lacked the 13th exon of Kirrel3 B which
Table 1 Sequence data obtained from amplicons with Kirrel3 primer set 1
370 amplicon
nucleotide sequence
TARRCWACTGCTGGATMCCCCGGTCATCATCAGCTGCTTGATGGTGGAGTGCTCCTCACCCTCCCGACCAGAGGCTGGTT
CCTTGTGGACAATTTCCACTCGGATATCATTTTTGGCTGACACAACACCTTTGAGATTTCTCTGGGAACGGGCACAGCAG
AACGCCACGATGGTTGCCATAAGGACGAGGAAGGCCACACCAGCTCCTACGGCCACCCCAATGATGACGGCCATCGGCAC
AGACTCTTGCTCCTTGAGCCGGATGATCTCAGTGTCGGAGCCGAAGCTGTTCCAGGCCGTGCAGTTGTAGATGGTCTGGA
AGTCGGCAAA
400 amplicon
nucleotide sequence
GTRMGTACTGCTGGATTMCCCCGGTCATCATCAGCTGCTTGATGGTGGAGTGCTCCTCACCCTCCCGACCAGAGGCTGGT
TCCTTGTGGACAATTTCCACTCGGATATCATTTTTGGCTGACACAACACCTTTGAGATTTCTCTGGGAACGGGCACAGCA
GAACGCCACGATGGTTGCCATAAGGACGAGGAAGGCCACACCAGCTCCTACGGCCACCCCAATGATGACGGCCATCGGCA
CAGACTCTGGTTCCWKSCCSGSTCCCAACTTCRTTTCCGAACCTTGCTCCTTGARCCSGATGATCTCRKWGWYGGASYCG
AAGYTGKYACAGGCCGTGCAGTTGTAGATGGTCTGGAAGTCGGCA
500 nucletotide sequence GGRARWRGTCKCACGCTTCGGCTCCGACACTGAGATCATCCGGCTCAAGGAGCAAGGTTCGGAAATGAAGTCGGGAGCCG
GGCTGGAAGCAGAGTCTGTGCCGATGGCCGTCATCATTGGGGTGGCCGTAGGAGCTGGTGTGGCCTTCCTCGTCCTTATG
GCAACCATCGTGGCGTTCTGCTGTGCCCGTTCCCAGAGAAATCTCAAAGGTGTTGTGTCAGCCAAAAATGATATCCGAGT
GGAAATTGTCCACAAGGAACCAGCCTCTGGTCGGGAGGGTGAGGAGCACTCCACCATCAAGCAGCTGATGCAGAGCAACT
GGCCGGCATTTTACAATAAACGTTCAGTCAATGGAATTGAATCAKCCATGGGAGATCTCTGGTGATGCCCTCGCCCACRC
GAGATGGACCGGGGTGAATTCCAGCAAGACTCASTCCTGAAACARCTGGAGGTCCTCAAAARACACTYCCTTTYYCCCCC
CCYCCTTTAMCCCCCTTTTCTCCTCTTTTTTTTCTTCTTTT
Amplicons correspond to those shown in Figure 2A and B. These sequences were blasted against the human genome via BLAST available at the NCBI to confirm
their identity as Kirrel3 splice variants.
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obtained).
Analysis of protein
Based on results obtained from our mRNA analysis we
wished to investigate Kirrel3 protein presence in human
skeletal muscle samples. A commercially available anti-
body that was raised against the intracellular AA 596-626
of Kirrel3 A was utilised. Lysates obtained from a previ-
ous downhill run (DHR) study by our group [32] were
utilised for the analysis. Baseline, 1 and 2 days post DHR
were the time points assessed. Multiple immunoreac-
tive proteins were detected in all human skeletal muscle
samples ranging in size from approximately 45-110 kDaFigure 3 Detection of Kirrel3 splice variants with primer set 2. A – PC
Kirrel3 B. mRNA was isolated from cultured human astrocytes (2 amplicons
and 4 and 24 hr post performance of a plyometric jumping exercise (ampl
amplicons detected in A based on sequence information.(Figure 4A). To assess for Kirrel3 specificity of the anti-
body, a blocking peptide was incubated with the antibody
prior to addition to the membrane. The immunoreac-
tive proteins observed at approximately 50-100 kDa
with antibody alone were eliminated (Figure 4B), thus pro-
viding support that these immunoreactive proteins may
be isoforms of Kirrel3. To confirm the protein presence
of Kirrel3 a second commercially available antibody that
was raised against a recombinant human Kirrel3 protein
(AA33-535 of NP_001288026) was tested on a selection of
lysates from the downhill running study. Immunoreactive
proteins were detected at approximately 70-75 kDA while
no immunoreactive proteins were detected at approxi-
mately 50-55 kDA and 110 (Figure 4C), which is inR amplicons obtained with Kirrel3 primer set 3 that was specific for
present) and adult human skeletal muscle biopsies obtained at rest
icons not evident). B – Schematic of the exon structure of both
Table 2 Sequence data obtained from amplicons with Kirrel3 primer set 2
610 nucleotide sequence AATARMATTGMGAGAGCTATGTGTTCATCCAAAATGCTGGCTGCCCTGCAGATGAAGTTCAGTCTAGTCCAGGTCAACCT
CAGCCTAGCGCCCACTCTGCCAGGCGCCATGTTGCCCAGGCTCACATACACCGATGCATCAGACCCACTCCCTGCCCCAG
GAGCTCACAGCACTGTTAGGACCCCTGTTCATTGCACTCCTGCTTACTTGCTCTCCGGGGCAGCCTAAGCCTGGCCTTTT
TCTCTGTCCCCCTCCCTGAGATCCCGGATCTCCCTCCCGTACTTCTCTGGGAACGGGCACAGCAGAACGCCACGATGGTT
GCCATAAGGACGAGGAAGGCCACACCAGCTCCTACGGCCACCCCAATGATGACGGCCATCGGCACAGACTCTKGTTCCWK
GCSSGSTACGAACTTCRTGTCCGARCCTAGSTCCTTGARSGSCATGATSTCGKWGATGGASTGGAAGYTGKYCCRSGCCA
TGYWGYTGATGATGGKGTGGAAGATGACCCCCTCSATGKTGCTGATGGTCWCGRYCGAAAAGAGRCCCTCCT
590 nucleotide sequence CATTCGATCGATTRSCGMKAGAGCWTGTGTTCATCCAAATGCTGGCTGCCCTGCAGATGAAGTTCAGTCTAGTCCAGGTC
AACCTCAGCCTAGCGCCCACTCTGCCAGGCGCCATGTTGCCCAGGCTCACATACACCGATGCATCAGACCCACTCCCTGC
CCCAGGAGCTCACAGCACTGTTAGGACCCCTGTTCATTGCACTCCTGCTTACTTGCTCTCCGGGGCAGCCTAAGCCTGGC
CTTTTTCTCTGTCCCCCTCCCTGAGATCCCGGATCTCCCTCCCGTACTTCTCTGGGAACGGGCACAGCAGAACGCCACGA
TGGTTGCCATAAGGACGAGGAAGGCCACACCAGCTCCTACGGCCACCCCAATGATGACGGCCATCGGCACAGACTCTTGC
TCCTTGAGCCGGATGATCTCAGTGTCGGAGCCGAAGCTGTTCCAGGCCGTGCAGTTGTAGATGGTCTGGAAGTCGGCCCG
CACGATGTTGCTGATGGTCAGGGTGGAGATGACGCCCTCCTCGGTGCTGATGGTCTCCACCGTATAGCGA
Amplicons correspond to those shown in Figure 3A. These sequences were blasted against the human genome via BLAST available at the NCBI to confirm their
identity as Kirrel3 splice variants.
Figure 4 Kirrel3 protein detection in adult human skeletal muscle. A – Western Blot results obtained with anti-human Kirrel3 antibody
directed toward intracellular region of Kirrel3 on skeletal muscle lysates obtained from adult human males at baseline, days one and two
after completion of a DHR exercise protocol. S = subject B – Western blot results from blocking peptide experiment. The antibody in A
was incubated with blocking peptide before being added to membrane containing skeletal muscle lysates obtained from adult human
males at baseline and one and two days post completion of a DHR exercise protocol. C – A second commercial antibody directed towards
the extracellular domain of Kirrel3 was used on a selection of lysates obtained from adult human male skeletal muscle day1 or 2 post
completion of the downhill running exercise bout. Ponceau staining was performed on membranes to demonstrate transfer and equal
protein loading.
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Discussion
Skeletal muscle is made up of multinucleated cells (muscle
fibres). The Drosophila homolog of Kirrel3, Kirre is
involved in enabling muscle cell fusion events. Hence,
Kirrel3 may be a putative muscle cell fusion regulator
in humans. There is currently no published data available
regarding Kirrel3 in adult human skeletal muscle. There-
fore, the primary aim of this research was to assess for
the presence of Kirrel3 in adult human skeletal muscle.
By using PCR and transcript sequencing, we provide the
first evidence that three alternatively spliced Kirrel3
mRNA transcripts are present in adult human skeletal
muscle. Results from western blot analysis provide sup-
port for the presence of Kirrel3 protein in adult human
skeletal muscle.
The mRNA data highlight that in adult human skeletal
muscle Kirrel3 mRNA expression levels are very low and
that using standard PCR may result in false negatives. A
nested PCR approach yielded a higher rate of Kirrel3 de-
tection. It will be of interest for future studies to exam-
ine Kirrel3 mRNA expression in a model that is known
to include a large amount of myogenesis such as can be
seen in some muscle pathologies. Primary human myo-
blast cell cultures would provide a useful system to further
investigate Kirrel3 and ascertain its importance to human
muscle cell fusion. Murine proprioceptive neurons have
been reported to express Kirrel3 [33], therefore their
contribution to Kirrel3 mRNA expression in adult human
skeletal muscle should also be investigated.
The physical process of transcribing Kirrel3 can be
regarded as a specialised event because, compared to the
vast majority of other genes within the human genome,
Kirrel3 spans a very large genomic region of approxi-
mately 580kB. Such a long genome span is likely to im-
pact on the rate of Kirrel3 mRNA transcript production.
RNA polymerase II has been reported to be capable of
transcribing large human genes at a rate of approxi-
mately 4 kb-min [34]. This rate of transcription suggests
that production of Kirrel3 mRNA transcripts would take
approximately 145 minutes. Previously produced tran-
scripts are likely to be translated or degraded within the
time period required to produce a Kirrel3 mRNA tran-
script. Such a time frame may result in a pulsatile occur-
rence of Kirrel3 mRNA in adult human skeletal muscle,
unless Kirrel3 is being continually transcribed. Such a
scenario may help explain the apparent discrepancy be-
tween the mRNA results in relation to Kirrel3 protein that
was detectable in all biopsy samples analysed from both
pre and post the DHR exercise intervention. Interestingly,
our findings in relation to human Kirrel3 are largely in
agreement with two different mouse studies focussingspecifically on Kirrel3. In the first study, mRNA has been
reported to be absent from mouse skeletal muscle [27],
while the second study reported strong protein detection
of Kirrel3 in mouse skeletal muscle [28].
Results from our western blot experiments varied de-
pending on the commercial antibody being used. Each
antibody targeted different epitopes with one being extra-
cellular and the other intracellular. The fact two immuno-
reactive proteins that migrated at approximately 70 and
75 kDa were detected by both antibodies, appears to sup-
port that these are Kirrel 3 proteins rather than break-
down products. However, the predicted molecular weight
of Kirrel3A is 85 kDa therefore the Kirrel proteins within
the 70 kDa range are likely to be one or two of the other
Kirrel3 splice variants present in human skeletal muscle.
It is possible that they represent one splice variant with
the larger having undergone post-translational modifica-
tion. Immunoprecipitation and mass spectrometry ana-
lysis will be useful in determining the identity of these
immunoreactive proteins.
The proteins detected at 50 and 55 kDa were detected
only when using the Kirrel3 antibody targeting the intra-
cellular domain. This antibody may be recognising partially
degraded Kirrel3 proteins or these could be alternative
truncated isoforms.
For analysis of mRNA, our primers were directed
towards the 3′ end region of Kirrel3 (intracellular coding
region) and we can only speculate on whether or not alter-
native splicing may occur further downstream towards the
5′ end (extracellular coding region) that would produce
even smaller Kirrel3 protein isoforms. If alternative splicing
occurs at the 5′ end this could explain why the extracellu-
lar targeting antibody did not detect proteins of similar size
as those detected by the intracellular targeting antibody. In
future, we suggest that 5′ race experiments should be
performed to provide useful information in evaluating this
possibility.
Our rationale for investigating Kirrel3 in human skeletal
muscle was derived from research studies in Drosophila
that demonstrated the involvement of two genes, Kirre
and Rst, in the muscle cell fusion process during embry-
onic development [19]. While our research findings do
not prove a role for Kirrel3 in the cell fusion process in
adult human muscle, they do raise interesting questions
regarding the function of Kirrel3 in human myogenesis
and even in uninjured human skeletal muscle fibres. Mur-
ine Kirrel3 is present in stromal cells [27] and co-culture
studies of Kirrel3 expressing stromal with hematopoietic
stem cells, demonstrated a role for the extracellular
domain of Kirrel3 in inhibiting hematopoietic stem cells’
differentiation [27]. Such a finding is particularly notable
since adult human skeletal muscle also contains stem cells
termed satellite cells [14]. Satellite cells, located within the
space between the basal lamina and plasma membrane of
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until activated by events such as muscle damage [11]. It
will therefore be of future interest to ascertain whether
Kirrel3 may be involved in regulating satellite cell differen-
tiation in human skeletal muscle.
In vitro, the extracellular domain of Kirrel3 is capable
of binding to the extracellular domain of nephrin, a type
1 transmembrane protein and member of the immuno-
globulin superfamily [28]. Nephrin is the mammalian
homolog to the Drosophila gene, sticks and stones, that
is essential for the muscle cell fusion process during em-
bryonic fly development [20]. Considering that a signifi-
cant body of evidence has emerged describing similarities
in cellular processes between fly and man [35] it is tempt-
ing to hypothesise that interaction of Kirrel3 and nephrin
in human skeletal muscle may facilitate the muscle cell fu-
sion process. Indeed, in a small mammal model, nephrin-/-
murine myoblasts displayed reduced fusion capabilities
during in vitro myogenesis [36].
Kirrel3 is part of the Kirrel gene family that contains
another two structurally similar members: Kirrel and
Kirrel2 [24]. In Drosophila redundancy is present between
Kirre and Rst with regard to the muscle cell fusion process
[19] and redundancy may also be present among the
Kirrel family members for the muscle cell fusion process
in humans. Such redundancy should be considered when
attempting to ascertain the possible roles of the Kirrel
family members in the human muscle cell fusion process.
In vitro primary myoblast culture studies should be fruit-
ful in this regard.
The splice variants, Kirrel3 A and B, that are present
in adult human skeletal muscle and/or astrocytes are
predicted to contain significantly different cytoplasmic
domains. Kirrel3 A, but not Kirrel3 B, is predicted to con-
tain a SH3 amphysisin binding domain and also a PDZ
binding domain. Such differences are likely to result in the
two isoforms having divergent functions. Amphysisin is a
protein whose function is not completely understood,
however, it is highly concentrated at nerve terminals [37].
The C-elegans homolog of Kirrel3 (an adhesion mol-
ecule named syg-1) is located at synapses [38] and hence,
amphysisin binding may regulate Kirrel3 A presence at
neural synapses or neuromuscular junctions.
The PDZ binding domain present in Kirrel3 A may
confer Kirrel3 with the ability to alter the polarity of the
cell in which it is expressed as the PDZ binding domain of
human Kirrel3 is capable of binding to the cell polarity
protein partitioning defective 3 (PARD3) [39]. Satellite
cells require PARD3 function in order to achieve asym-
metric cell division [40]. The asymmetric cell division of
satellite cells enables diversity that is thought to be im-
portant in the maintenance of the satellite cell pool. A
subset of satellite cells in injured skeletal muscle are highly
proliferative while another subset of cells retains theability to return to quiescence [40]. It will therefore be of
future interest to ascertain whether Kirrel3 is present in
satellite cells and if so, whether it regulates asymmetric
division via its interaction with PARD3.
Conclusion
In conclusion, the results presented here demonstrate
for the first time that there are at least 3 splice variants
of Kirrel3 present in adult human skeletal muscle, two
of which have never previously been identified in human
muscle. Importantly, mRNA of all splice variants was
not always present, a finding with potential physiological
relevance. These initial discoveries highlight the need for
more molecular and functional studies. Full length se-
quence information should be obtained on all Kirrel3
mRNA transcripts in order to predict the translated
Kirrel3 proteins. Physiological studies should be done to
confirm involvement in fusion, or not. Production of iso-
form specific anti Kirrel3 antibodies will enable identifica-
tion of the cellular localisation of the different Kirrel3
isoforms. Obtaining such information will aid in our un-
derstanding of Kirrel3 and its function in human skeletal
muscle.
Methods
Ethics statement
Healthy young men aged between 18-28 years of age
volunteered to participate in one of two studies aiming
to describe molecular and physiological responses to
exercise-induced muscle damage. Participants were in-
formed about the purpose and risks of the study in which
they were to participate before signing an informed con-
sent document. The experimental protocols were approved
by the Committee for Human Research at Stellenbosch
University and the studies were conducted according to
the ethical guidelines and principles of the International
Declaration of Helsinki.
Plyometric jumping protocol
Participants were first taught how to perform the squat
jump exercise. Subsequently their maximum squat jump
height was measured. For the squat jump exercise inter-
vention participants preformed 100 squat jumps at 90%
of their maximum jump height. Jumps were divided into
sets of 10 with 1 minute rest interval between each set.
Prior to performing the 100 squat jumps participants
exercised at a light to moderate intensity for 5 minutes
on a treadmill.
Downhill running protocol
The protocol used here was previously described [32]. In
brief, participants performed a 60-minute intermittent
DHR protocol (12 × 5 min bouts at 85% VO2max, 10%
decline) on a motorized treadmill. They were allowed a
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pants were able to complete all twelve bouts.
Biopsies
Muscle biopsies were obtained from the vastus lateralis
muscle using a 5 mm trephine biopsy needle with assisted
suction. Baseline biopsies were obtained from participants
who had not engaged in any strenuous physical activity
7 days prior to the biopsy. Biopsies from participants who
had performed the plyometric jumping protocol were ob-
tained 4 and 24 hrs post completion of the protocol. Base-
line and 24 hr biopsies were taken from the right leg while
the 4 hr biopsy was taken from the left leg. Similarly, biop-
sies from participants who completed the downhill run-
ning protocol were taken at baseline and one and two
days post downhill running in a consistent manner. Biop-
sies were frozen in liquid nitrogen cooled isopentane and
stored at -80°C until use.
Cell culture
Human astrocytes (SciencCell research laboratories San
Diego CA Catalog #1800) were seeded at a density of 105
in 6 well plates (BD Bioscience) in growth media which
contained 89% Dulbecco’s Modified Eagle Medium, 1%
N-2 Supplement 100X, 10% Fetal Bovine serum (all Life
Technologies). Once cells had reached 70% confluence
they were lysed for RNA and protein isolation. Growth
media was removed from wells before 200 ul of Tripure
(Roche) was added per well of a 6 well plate and incubated
at room temperature for 5 minutes with occasional gentle
agitation. For protein isolation 150 ul of protein lysis buf-
fer was added per well and incubated on ice for 5 minutes
with occasional gentle agitation.
RNA isolation and RT-PCR
Muscle biopsies were sectioned on a cryostat (Leica Bio
systems) at -20°C to obtain approximately 20 mg of tissue.
Samples were then homogenised on ice in 1 ml of Tripure
(Roche). RNA was isolated according to manufacturer’s
guidelines and suspended in TE Buffer and stored at -20°C
until use. For reverse transcription (RT) 1ug of RNA was
DNAse treated according to manufacturers (Roche) guide-
lines. Subsequently the 1 ug of DNAse treated RNA was
reverse transcribed using random hexamers in accordance
with manufacturers (Roche – Transcriptor First strand
cDNA synthesis kit) guidelines. For PCR a 2 ul aliquot of
cDNA corresponding to 50 ng of RNA was used. Each
PCR consisted of a total volume of 25 ul. Primers (Sigma
Life Science) were used at a 1 uM concentration and
remaining components of PCR followed manufacturers
(Roche – Faststart PCR Master) recommended protocol.
For semi nested PCR a 2 ul volume from the initial PCR
was used in the second PCR instead of 2 ul of cDNA. Post
PCR the 25 ul volume was mixed with 6 ul of loadingbuffer (75% v/v glycerol, 0.02% w/V bromophenol blue,
10 mM Tris Base, 1 mM EDTA, 0.2% w/v SDS) and loaded
onto a 1% agarose gel which contained sybr safe (Life
Technologies) at 1X concentration and electrophoresed
alongside a 100 bp ladder (Life Technologies). Gels were
visualised on a Chemidoc MP (Biorad) that was supported
with Image Lab software (Biorad). Kirrel3 Primer sets
used were as follows Primer set 1 – Forward primer
GCCGACTTCCAGACCATCTA, Reverse primer –
TTTGAGGACCTCCAGCTGTT, Primer set 2 - Forward
Primer CGCTATACGGTGGAGACCAT, Reverse Primer
Same as primer set 1. Primer set 3 – Forward primer
same as primer set 2, Reverse Primer – CGCTTTT
CCCCCTATCTTTC. Amplicons were excised from the
agarose gel, purified and sequenced at the central analytical
facility at Stellenbosch University. For GAPDH primer set
used was Forward primer – AATCCCATCACCATCTTC
CA, Reverse primer - TGACAAAGTGGTCGTTGAGG.
Protein isolation and Western blot
Muscle biopsies were sectioned on a cryostat (Leica
Biosystems) at 12 μm to obtain ~20 mg of tissue. Samples
were homogenised on ice in 700 ul of lysis buffer (50 mM
Tris HCL PH 7.5, 150 mM NaCl, 1 mM EDTA, 1% v/v
nonidet p40, 0.25% w/v sodium deoxycholate 1 mM NaF,
1 mM Na3V04, 1 mM PMSF, 1 ug/ml leupeptin, 1 ug/ml
pepstatin, 1 ug/ml aprotinin). Protein concentration was
measured via a Bicinchoninic acid (BCA) kit (Thermo
Fischer Scientific) using Bovine serum albumin (Roche) as
standards. 30 ug of protein lysate was mixed with 5×
Lamelli buffer (60 mM Tris HCL PH6.8, 2% SDS, 10% gly-
cerol, 5% B-mercaptoethanol, 0.01% bromophenol blue)
to yield 1× and electrophoresed using the Mini Protean
Tetra system (Biorad). Post electrophoresis proteins
were transferred to a nitrocellulose membrane (Amsheram
Hybond ECL Nitrocellulose membranes GE Healthcare) via
Trans Blot Turbo (Biorad) and membranes were stained
with ponceau S to confirm transfer and equal protein
loading. Subsequently membranes were washed 3 times
for 5mins with 1× TBST (50 mM Tris, 150 mM NaCl,
0.1% tween 20, pH 8.3) and then blocked for 1 hr at
room temp in 1× TBST and 5% semi skimmed milk.
The intracellular targeting primary rabbit anti human
Kirrel 3 antibody (102960 Abcam Cambridge UK) and
the extracellular targeting primary sheep anti Kirrel 3 anti-
body (AF4910 R and D systems Minneapolis USA) were
incubated over night at room temp with gentle agitation
in 1× TBST with 5% semi skimmed milk. For blocking
peptide experiment intracellular targeting primary anti
human Kirrel 3 antibody was incubated with blocking
peptide at a ratio of 1:4 for 3 hrs at room temperature
with gentle agitation. Post primary antibody incubation
or antibody and blocking incubation membranes were
washed 3 times for 5 mins and subsequently incubated
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ling) at 1:15,000 or donkey anti sheep HRP conjugated
secondary ( 6900 Abcam Cambridge UK) at 1:30,000
for 1 hr at room temp in 1x TBST and 5% milk. Mem-
branes were subsequently washed 6X for 5mins followed
by incubation with chemiluminescence detection reagents
(Femto, Pierce Thermo Fischer Scientific). Membranes
were visualised on a Chemidoc MP (Biorad) which was
supported with Image Lab software (Biorad).
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